These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36580031)

  • 21. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
    Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors.
    Fujiwara SI; Ikeda K; Kino S; Tanaka A; Hasegawa Y; Fujino K; Makino S; Matsumoto M; Yokohama A; Takeshita A; Muroi K
    Int J Hematol; 2020 Jun; 111(6):833-839. PubMed ID: 32172447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow harvest from unrelated donors-up-to-date methodology.
    Pruszczyk K; Skwierawska K; Król M; Moskowicz A; Jabłoński D; Torosian T; Piotrowska I; Urbanowska E; Wiktor-Jędrzejczak W; Snarski E
    Eur J Haematol; 2017 Oct; 99(4):357-365. PubMed ID: 28719093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.
    Zhang C; Chen XH; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Gong Y; Zeng DF; Wang QY
    Transfus Med; 2010 Jun; 20(3):169-77. PubMed ID: 20136781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
    Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
    Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of hematopoietic stem cell donation in glucose 6 phosphate dehydrogenase-deficient donors.
    Pilo F; Baronciani D; Depau C; Targhetta C; Pani M; Manconi R; Fadda MG; Mamusa AM; Angelucci E
    Bone Marrow Transplant; 2013 Jan; 48(1):36-9. PubMed ID: 22732702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres.
    Coluccia P; Crovetti G; Del Fante C; Dallavalle FM; Laszlò D; Ferremi P; Marenchino D; Santoleri L; De Filippo C; Mattana F; Mariani L; Perseghin P; Ravagnani F
    Blood Transfus; 2012 Oct; 10(4):440-7. PubMed ID: 22871823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.
    Stroncek DF; Holland PV; Bartch G; Bixby T; Simmons RG; Antin JH; Anderson KC; Ash RC; Bolwell BJ; Hansen JA
    Blood; 1993 Apr; 81(7):1940-6. PubMed ID: 8461478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors.
    Valentini CG; Ceglie S; Fatone F; Metafuni E; Pellegrino C; Chiusolo P; Sica S; Teofili L
    Front Oncol; 2024; 14():1389068. PubMed ID: 38873255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests.
    Li Y; Chang Y; Xu L; Zhang X; Huang X
    Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of bone marrow stem cell donation: a review.
    Bosi A; Bartolozzi B
    Transplant Proc; 2010; 42(6):2192-4. PubMed ID: 20692441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
    Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Parameswaran V; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Confer DL; Shaw BE
    Haematologica; 2019 Apr; 104(4):844-854. PubMed ID: 30381298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of principles of blood management to healthy donor bone marrow harvesting.
    Kim-Wanner SZ; Luxembourg B; Schmidt AH; Schäfer R; Möller N; Herbert E; Poppe C; Hümmer C; Bunos M; Seifried E; Bonig H
    Vox Sang; 2020 Nov; 115(8):802-812. PubMed ID: 32633825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo Study.
    Fagioli F; Quarello P; Pollichieni S; Lamparelli T; Berger M; Benedetti F; Barat V; Marciano R; Rambaldi A; Bacigalupo A; Sacchi N
    Hematology; 2014 Jan; 19(1):1-9. PubMed ID: 23677141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collection of autologous blood for bone marrow donation: how useful is it?
    Parkkali T; Juvonen E; Volin L; Partanen J; Ruutu T
    Bone Marrow Transplant; 2005 Jun; 35(11):1035-9. PubMed ID: 15821763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe events in donors after allogeneic hematopoietic stem cell donation.
    Halter J; Kodera Y; Ispizua AU; Greinix HT; Schmitz N; Favre G; Baldomero H; Niederwieser D; Apperley JF; Gratwohl A
    Haematologica; 2009 Jan; 94(1):94-101. PubMed ID: 19059940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.